Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLC is a research paper published in Journal of Thoracic Oncology (2023). On theSindex it has a DataRank of 0.385. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Horizon 2020 Marie Skłodowska-Curie Actions
Grant: 799724
Development of a novel genetically engineered mouse model to study the role of HDAC6 in oncogenesis and metastasis of non-small cell lung cancer.
National Cancer Institute
Grant: PO1CA15430
National Cancer Institute
Grant: ROICA219670
NCI NIH HHS
Grant: R35 CA242379
NCI NIH HHS
Grant: P30 CA014051
NCI NIH HHS
Grant: PO1 CA015430
NCI NIH HHS
Grant: R01 CA219670
NIGMS NIH HHS
Grant: T32 GM007753
NIGMS NIH HHS
Grant: T32 GM144273
NCI NIH HHS
Grant: P30 CA016087
National Institutes of Health
Conquer Cancer Foundation
Sage Therapeutics
Fields of Study
MeSH Terms
Keywords